Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

GDC-1971 is an inhibitor of Src homology region 2 domain-containing phosphatase 2 (SHP-2; IC50 = <0.001 µM).1 It is selective for SHP-2 over SHP-2 containing a glutamate-to-lysine substitution at position 76 (SHP-2E76K; IC50 = 0.17 µM). GDC-1971 reduces the levels of phosphorylated ERK in a reporter assay using KYSE-520 esophageal cancer cells (IC90 = 0.012 µM) and inhibits proliferation of the same cells (IC50 = 0.32 µM). In vivo, GDC-1971 (30 or 100 mg/kg two times per day) reduces tumor volume in KYSE-520 and NCI H358 non-small cell lung cancer (NSCLC) mouse xenograft models.
WARNING This product is not for human or veterinary use.
1. Identification of GDC-